T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

Atherosclerotic lesions are infiltrated by macrophages and T lymphocytes, potentially reactive to pathogens. We studied in vivo activated T lymphocytes that infiltrate atherosclerotic plaques of Helicobacter pylori-infected patients with or without anti-Chlamydia pneumoniae antibodies. In all atherosclerotic lesions, T helper type 1 (Th1) cells were predominant. C. pneumoniae-specific T cells were detected only in the plaques of anti-C. pneumoniae seropositive patients, whereas H. pylori-specific T cells were found in the gastric mucosa but not in the plaques of the same patients. Plaque-derived Th1 cells expressed cytotoxicity, proapoptotic activity, and help for monocyte tissue factor production. Although multifactorial, atherosclerosis can be regarded as a Th1-driven immunopathological condition.

[1]  P. Visca,et al.  Antibodies to 60-Kilodalton Heat Shock Protein and Outer Membrane Protein 2 of Chlamydia pneumoniae in Patients with Coronary Heart Disease , 2002, Clinical and Vaccine Immunology.

[2]  S. Blankenberg,et al.  Impact of Infectious Burden on Extent and Long-Term Prognosis of Atherosclerosis , 2002, Circulation.

[3]  G. Millonig,et al.  Atherosclerosis as an autoimmune disease: an update. , 2001, Trends in immunology.

[4]  S. Blankenberg,et al.  Impact of Viral and Bacterial Infectious Burden on Long-Term Prognosis in Patients With Coronary Artery Disease , 2001, Circulation.

[5]  S. Blankenberg,et al.  Cytomegalovirus Infection With Interleukin-6 Response Predicts Cardiac Mortality in Patients With Coronary Artery Disease , 2001, Circulation.

[6]  G. Hansson,et al.  Chlamydia pneumoniae Infection Does Not Induce or Modify Atherosclerosis in Mice , 2001, Circulation.

[7]  A. Tedgui,et al.  Current perspective on the role of apoptosis in atherothrombotic disease. , 2001, Circulation research.

[8]  R. Frye,et al.  Molecular Fingerprint of Interferon-&ggr; Signaling in Unstable Angina , 2001, Circulation.

[9]  F. Cianchi,et al.  H(+),K(+)-atpase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. , 2001, Gastroenterology.

[10]  G. Hansson.  Immune mechanisms in atherosclerosis. , 1989, Arteriosclerosis, thrombosis, and vascular biology.

[11]  A. Daugherty,et al.  Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice , 2000 .

[12]  R. Virmani,et al.  Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. , 2000, The American journal of pathology.

[13]  M. Shirai,et al.  Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue. , 2000, The Journal of infectious diseases.

[14]  P. Saikku,et al.  Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[15]  P. Kirkpatrick,et al.  T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens , 1999, Clinical and experimental immunology.

[16]  W. März,et al.  Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. , 1999, Circulation.

[17]  D. Pfeiffer,et al.  Serological evidence of Chlamydia pneumoniae lipopolysaccharide antibodies in atherosclerosis of various vascular regions. , 1999, VASA. Zeitschrift fur Gefasskrankheiten.

[18]  M. D’Elios,et al.  Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma. , 1999, Gastroenterology.

[19]  P. Libby,et al.  Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. , 1999, The Journal of clinical investigation.

[20]  Jianhui Zhu,et al.  Infection and atherosclerosis: emerging mechanistic paradigms. , 1999, Circulation.

[21]  U. Andersson,et al.  Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. , 1999, Atherosclerosis.

[22]  M. Rosenfeld,et al.  Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. , 1999, The Journal of infectious diseases.

[23]  J. Danesh,et al.  Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease , 1999, Heart.

[24]  G. Zhong,et al.  The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. , 1999, The Journal of clinical investigation.

[25]  J. Penninger,et al.  Chlamydia infections and heart disease linked through antigenic mimicry. , 1999, Science.

[26]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[27]  P. Libby,et al.  Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. , 1998, Circulation.

[28]  U. Mamat,et al.  Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. , 1998, Journal of the American College of Cardiology.

[29]  J. Harlan,et al.  Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbα , 1998, The Journal of experimental medicine.

[30]  P. Allavena,et al.  Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.

[31]  G. Pizzolo,et al.  Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. , 1997, The American journal of pathology.

[32]  I. Fong,et al.  Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. , 1997, Circulation.

[33]  P. Libby,et al.  Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[34]  M. D’Elios,et al.  Different cytokine profile and antigen‐specificity repertoire in Helicobacter pylori‐specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer , 1997, European journal of immunology.

[35]  A. Tall,et al.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.

[36]  S. Swain,et al.  Single cell analyses of cytokine production. , 1997, Current opinion in immunology.

[37]  B. Hemmer,et al.  Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis. , 1997, Journal of immunology.

[38]  V. Fuster,et al.  Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. , 1997, Circulation.

[39]  A. Bertoletti,et al.  Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. , 1997, Gastroenterology.

[40]  C. Potter,et al.  The nPCR detection of Chlamydia pneumoniae and Chlamydia trachomatis in children hospitalized for bronchiolitis. , 1996, The Journal of infection.

[41]  L. Demer,et al.  Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. , 1996, The Journal of clinical investigation.

[42]  M. Cooper,et al.  Expression and function of Fas antigen on activated murine B cells , 1996, European journal of immunology.

[43]  J. Witztum,et al.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  F. Annunziato,et al.  Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection , 1994, The Journal of experimental medicine.

[45]  H Hengartner,et al.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.

[46]  L. Fabbri,et al.  Allergen exposure induces the activation of allergen‐specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders , 1993, European journal of immunology.

[47]  M. Leinonen,et al.  Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study , 1992, Annals of Internal Medicine.

[48]  M. de Carli,et al.  Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: the help of Th1 clones is limited by their cytolytic capacity , 1991, The Journal of experimental medicine.

[49]  M. de Carli,et al.  Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. , 1991, Journal of immunology.

[50]  T. Edgington,et al.  Clonal analysis of CD4+ T helper cell subsets that induce the monocyte procoagulant response. , 1990, Cellular immunology.

[51]  G. Hansson,et al.  Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.

[52]  G. Bondjers,et al.  Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.